Next Generation Of Medical Devices And Diagnostics
Funder
National Health and Medical Research Council
Funding Amount
$2,738,220.00
Summary
This Investigator Project will deliver innovative technologies that improve patient wellbeing, make significant economic impact and contribute to answering complex biological questions. This will happen via delivering breakthrough technologies to prevent infections and diagnose diseases – two area that currently require substantial technological advances. In addition to helping patients and clinicians, the project will also deliver solid body of new knowledge that is currently missing.
‘Intelligent’ Antibacterial Coatings For Improving Outcomes With Infections Associated With Dialysis Catheters
Funder
National Health and Medical Research Council
Funding Amount
$653,806.00
Summary
The outcomes of this projects will set the framework for the rational design of novel and ’intelligent‘ antibacterial coating that selectively respond to the ‘virulent’ bacteria that cause such significant and recurrent issues in routine kidney dialysis regimens and will underpin future academic and commercial collaborative efforts to rationally-design and manufacture kidney dialysis catheters with substrate surface characteristics that will enhance utility, function and clinical application;
Understanding Health Professionals' Infection Control Practices In The Acute Care Setting
Funder
National Health and Medical Research Council
Funding Amount
$151,196.00
Summary
Health-care acquired infections have a considerable personal, social and economic impact in Australia, and better understanding of the causes of these infections is necessary. Failure by health professionals to follow infection control recommendations has important consequences in terms of the personal risk of acquiring an infection as well as the risk of infection transmission to patients. In Australia surgical site infections alone are estimated to cost as much as 268 million dollars a year. H ....Health-care acquired infections have a considerable personal, social and economic impact in Australia, and better understanding of the causes of these infections is necessary. Failure by health professionals to follow infection control recommendations has important consequences in terms of the personal risk of acquiring an infection as well as the risk of infection transmission to patients. In Australia surgical site infections alone are estimated to cost as much as 268 million dollars a year. Health-care acquired infections are associated with poorer health outcomes, a greater probability of prolonged hospital stays, greater re-hospitalisation rates, and significant reductions in health related quality of life. In this qualitative study we will use grounded theory and a comparative analysis strategy. We will initially identify participants sampled from health professionals employed in the acute care setting at a major teaching hospital in Perth, Western Australia. We will seek representation of a range of health professionals recruited from multiple occupational groups, including doctors, nurses and paramedical staff who have direct patient contact in the study sample. Sampling will also aim to recruit participants from a number of different acute care areas within the hospital, and staff with a range of individual characteristics, experiences and beliefs. We will interview a range of health care workers in order to explore their experiences of engagement in infection control practices and the factors influencing these experiences. We aim to develop a substantive theory that explains health professionals' engagement in high-risk infection control practices in the acute care setting. This will have implications for current understandings of the factors influencing adherence to recommended infection control practices, current theoretical perspectives which guide infection control practice, and strategies used to promote compliance with recommended practices.Read moreRead less
Dissecting The Molecular Basis For Emerging Alcohol Tolerance In VRE
Funder
National Health and Medical Research Council
Funding Amount
$836,620.00
Summary
Infections caused by vancomycin resistant Enterococcus faecium (VREfm) are a major and growing problem in health care facilities around Australia. We have observed that VREfm is becoming significantly more resistant to killing by alcohol, probably due the increasing use of alcohol-based hand wash products. This project will identify how VREfm is becoming alcohol tolerant, knowledge that will be used to develop alternative disinfection methods or other intervention strategies to stop its spread.
Anti-sporulation Strategies For Clostridium Difficile Infections
Funder
National Health and Medical Research Council
Funding Amount
$651,559.00
Summary
Hospital-acquired infections with the bacterium Clostridium difficile are a major global public health concern with highly virulent isolates emerging overseas in 2002 and in Australia in 2010. These strains have spread through our hospitals and are also found in the community. This project will increase our understanding of how these strains spread and will provide knowledge that is critical for developing improved strategies for preventing these infections.
Defining Burden And Drivers Of Antibiotic Resistant Bacteria And Healthcare Infections To Plan Cost-effective Interventions
Funder
National Health and Medical Research Council
Funding Amount
$340,891.00
Summary
I am an Infectious Diseases physician and early career researcher with interests in drug resistant infections and hospital infections. The research program will describe the threat of drug-resistant infections by demonstrating which superbugs have the greatest impact and by describing how these bacteria disperse through our health system. The research will evaluate and prioritise strategies to confront these problems.
To Investigate Rates Of Peritonitis In Incident Peritoneal Dialysis Patients In Australia And Perform A Pilot Study Aimed At Reducing These Rates
Funder
National Health and Medical Research Council
Funding Amount
$92,314.00
Summary
Overall aims: To establish how much variation in PD practice exists between renal units in Australia; to establish current practice in 8 units; to perform an intervention study in 8 units; to analyse registry data re peritonitis in PD patients; to conduct interviews with PD patients who have had peritonitis. Expected outcomes: To establish if practice variation is associated with peritonitis rates; to see if active guideline implementation leads to better peritonitis rates; to establish the reas ....Overall aims: To establish how much variation in PD practice exists between renal units in Australia; to establish current practice in 8 units; to perform an intervention study in 8 units; to analyse registry data re peritonitis in PD patients; to conduct interviews with PD patients who have had peritonitis. Expected outcomes: To establish if practice variation is associated with peritonitis rates; to see if active guideline implementation leads to better peritonitis rates; to establish the reasons why therapy fails.Read moreRead less
Defining A Role For TLR7/8 In Helicobacter Pylori Infection
Funder
National Health and Medical Research Council
Funding Amount
$568,007.00
Summary
Helicobacter pylori is a bacterium responsible for chronic gastritis and is associated with development of gastric cancer. In this project, we will investigate how the immune system interacts with H. pylori during colonisation – focusing on a sensor of the immune system, called TLR8 (and its mouse equivalent, TLR7).
Improving Clinical Outcomes Of Antimicrobial Resistant Infections With A Drug-free Intervention
Funder
National Health and Medical Research Council
Funding Amount
$999,581.00
Summary
Superbugs, or antimicrobial-resistant pathogens, cause recurring infections and non-healing wounds after surgery as existing therapies fail to effectively kill them. We will develop a medical device to fight superbugs with UV light that is effective against bacteria and fungi without causing harm to human cells. This could eradicate superbugs at infection sites, aid wound healing and actively improve health outcomes after surgery.